Milica Pavlovic

Title: Milica Pavlovic: Innovator in Cancer Metastasis Research

Introduction

Milica Pavlovic is a prominent inventor based in Lajkovac, Serbia. She has made significant contributions to the field of cancer research, particularly in the diagnosis and treatment of breast cancer metastasis. With a total of seven patents to her name, her work is paving the way for advancements in cancer therapies.

Latest Patents

Milica's latest patents include a method for the diagnosis, prognosis, and treatment of breast cancer metastasis. This invention focuses on determining if the c-MAF gene is amplified in a primary tumor sample. Additionally, it provides methods for diagnosing and predicting the tendency to develop bone metastasis in breast cancer patients. Another notable patent involves a method for predicting early bone metastasis in subjects suffering from breast cancer. These inventions also highlight the use of c-MAF inhibitors as therapeutic targets for treating various types of breast cancer metastasis.

Career Highlights

Throughout her career, Milica has worked with esteemed organizations such as the Fundacio Institut De Recerca Biomedica in Barcelona and the Institucio Catalana De Recerca I Estudis Avancats. Her research has garnered attention for its innovative approaches to understanding cancer metastasis.

Collaborations

Milica has collaborated with notable professionals in her field, including Roger Gomis and Anna Arnal. These partnerships have contributed to the advancement of her research and the development of her patents.

Conclusion

Milica Pavlovic's work in cancer research exemplifies the impact of innovation in medical science. Her patents are crucial for improving the diagnosis and treatment of breast cancer metastasis, showcasing her dedication to advancing healthcare solutions.